Novo Nordisk A S NVO
NYSE NVO
$44.58 -0.58 (-1.28%)
As of: Sep 9, 2026 · 3:59 PM EDT

Novo Nordisk A S (NVO) Non Operating Interest Expenses (2012 - 2019)

Novo Nordisk A S's (NVO) quarterly Non Operating Interest Expenses came in at $4.0 billion in Q4 2019, up 7163.64% quarter-over-quarter from $55.0 million in Q1 2016.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Novo Nordisk A S (NVO) Non Operating Interest Expenses (2012 - 2019) Analysis & Trends

Novo Nordisk A S (NVO) has reported Non Operating Interest Expenses for 6 consecutive years, with $4.0 billion the latest figure, recorded in Q4 2019.

Peer Set

Peer Comparison

All peers
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 4.00 Bn
Mar 31, 2016 55.00 Mn
Sep 30, 2015 276.00 Mn
Jun 30, 2015 252.00 Mn
Mar 31, 2015 251.00 Mn
Dec 31, 2014 -63.00 Mn
Sep 30, 2014 79.00 Mn
Jun 30, 2014 26.00 Mn
Mar 31, 2014 58.00 Mn
Dec 31, 2013 31.00 Mn
Sep 30, 2013 20.00 Mn
Jun 30, 2013 47.00 Mn
Mar 31, 2013 19.00 Mn
Dec 31, 2012 24.00 Mn
Sep 30, 2012 70.00 Mn
Jun 30, 2012 149.00 Mn
Mar 31, 2012 66.00 Mn